The North America Subcutaneous Drug Delivery Devices Market continues to hold a leading position due to its advanced healthcare infrastructure, increasing adoption of self-administration therapies, and growing prevalence of chronic diseases requiring long-term treatment. Pharmaceutical manufacturers and healthcare providers across the region are increasingly utilizing subcutaneous drug delivery technologies to improve patient convenience, treatment adherence, and clinical outcomes. The growing focus on home healthcare and minimally invasive drug administration further supports market expansion throughout North America.

According to The Insight Partners, the Subcutaneous Drug Delivery Devices Market was valued at US$ 9,243.80 million in 2018 and is projected to reach US$ 17,290.47 million by 2027. The market is anticipated to register a CAGR of 7.4% during 2019–2027, reflecting the increasing demand for efficient drug delivery solutions across healthcare settings.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006411

Subcutaneous Drug Delivery Devices Market Overview

Subcutaneous drug delivery devices are designed to administer medications into the fatty tissue beneath the skin, allowing controlled and efficient absorption into the bloodstream. These devices are widely adopted for delivering biologics, insulin, hormones, and other specialty pharmaceuticals that require frequent administration.

The increasing shift toward patient-centric healthcare has significantly contributed to the adoption of subcutaneous delivery systems, enabling patients to receive treatments outside traditional clinical environments while maintaining treatment effectiveness.

Market Size Analysis

The global Subcutaneous Drug Delivery Devices Market demonstrates strong growth potential over the forecast period. Rising healthcare expenditure, technological innovation in drug delivery platforms, and increasing demand for self-injection devices continue to strengthen market expansion.

The market is expected to nearly double from US$ 9,243.80 million in 2018 to US$ 17,290.47 million by 2027, supported by a steady CAGR of 7.4%. This growth highlights the increasing importance of advanced drug delivery technologies in improving patient experience and expanding access to biologic therapies.

Key Growth Drivers

Rising Adoption of Self-Administration

Healthcare systems are increasingly encouraging home-based treatment models that reduce hospital visits while improving patient comfort. Subcutaneous drug delivery devices support this transition by enabling convenient and reliable medication administration.

Growing Demand for Biologic Therapies

The expanding use of biologic drugs across multiple therapeutic areas has increased the need for efficient delivery devices capable of providing accurate dosing with minimal discomfort.

Patient-Centric Healthcare

Modern healthcare strategies emphasize improving treatment adherence and quality of life. Subcutaneous drug delivery devices offer user-friendly administration methods that support long-term therapy management.

Continuous Product Innovation

Manufacturers continue to focus on improving injection technologies, ergonomic device designs, and ease of use, contributing to broader adoption among patients and healthcare professionals.

Emerging Market Trends

Several industry trends continue to shape the future of the Subcutaneous Drug Delivery Devices Market.

The increasing preference for minimally invasive treatment options is encouraging greater utilization of subcutaneous delivery systems across healthcare facilities. Healthcare providers are also emphasizing home-based care, creating favorable conditions for advanced injection devices.

Technological advancements in device engineering continue to improve safety, dosing precision, and patient convenience. These innovations are expected to strengthen market growth during the forecast period.

Growing investments in pharmaceutical research and the commercialization of biologic drugs further support demand for reliable drug delivery platforms capable of meeting evolving therapeutic requirements.

Competitive Landscape

The market remains highly competitive, with leading companies investing in product innovation, manufacturing capabilities, and strategic collaborations to strengthen their market positions.

Top Key Players

• Becton, Dickinson and Company
• Gerresheimer AG
• Ypsomed Holding AG
• SHL Medical AG
• West Pharmaceutical Services, Inc.
• Haselmeier AG
• Nemera
• Owen Mumford Ltd.
• Antares Pharma, Inc.
• Medtronic plc

These companies continue to focus on expanding their product portfolios while developing innovative drug delivery technologies to address the growing demand for patient-friendly therapeutic solutions.

Future Outlook

The future outlook for the Subcutaneous Drug Delivery Devices Market remains highly positive. Increasing adoption of biologic medicines, expanding home healthcare services, and continued technological advancements are expected to support long-term market growth.

As pharmaceutical companies develop more therapies suitable for subcutaneous administration, demand for advanced delivery devices will continue to rise. Healthcare providers are also expected to increase adoption of these systems to improve treatment efficiency and patient satisfaction. With the market projected to reach US$ 17,290.47 million by 2027, supported by a 7.4% CAGR, the industry is well positioned for sustained expansion and continued innovation.

Trending Reports:

·         Medical Second Opinion Market Growth and Forecast by 2031

·         Blood Filter Market Growth and Recent Trends by 2028

·         Brain Implants Market Dynamics and Developments by 2030

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:
Contact Person: Ankit Mathur 
E-mail: [email protected]
Phone: +1-646-491-9876

Also Available in : Korean|German|Japanese|French|Chinese|Italian|Spanish